You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PLX3397

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Beijing, Guangzhou, Seoul (PLX3397)

Active, not recruiting
Has Results
  • Melanoma
  • PLX3397
  • Beijing, Beijing, China
  • +4 more
Apr 21, 2022

Sarcoma, Malignant Peripheral Nerve Sheath Tumors Trial in United States (PLX3397, Sirolimus)

Recruiting
  • Sarcoma
  • Malignant Peripheral Nerve Sheath Tumors
  • Iowa City, Iowa
  • +4 more
Aug 26, 2021

Solid Tumor Trial in United States (PLX3397)

Completed
Has Results
  • Solid Tumor
  • PLX3397
  • Scottsdale, Arizona
  • +12 more
Dec 6, 2021

Malignant Melanoma Trial in United Kingdom (PLX3397)

Completed
  • Malignant Melanoma
  • PLX3397
  • Manchester, Greater Manchester, United Kingdom
  • +7 more
Aug 11, 2021

Tenosynovial Giant Cell Tumor Trial in Japan (Pexidartinib)

Recruiting
  • Tenosynovial Giant Cell Tumor
  • Aichi, Japan
  • +5 more
Jun 29, 2022

Gastrointestinal Stromal Tumors Trial in United States (PLX9486, Pexidartinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
  • +5 more
Apr 30, 2021

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey

Completed
  • Stage I Prostate Adenocarcinoma
  • +2 more
  • Antiandrogen Therapy
  • +3 more
  • Detroit, Michigan
  • +2 more
Oct 4, 2020

Colorectal Cancer, Pancreatic Cancer, Metastatic Cancer Trial in Lyon, Toulouse (Pexidartinib, Durvalumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Lyon, France
  • +1 more
Sep 2, 2021

Metastatic Breast Cancer Trial in San Francisco, Durham, Nashville (PLX3397, Eribulin)

Completed
Has Results
  • Metastatic Breast Cancer
  • San Francisco, California
  • +2 more
Jul 2, 2020

Hodgkin Lymphoma Trial in United States (PLX3397)

Completed
Has Results
  • Hodgkin Lymphoma
  • PLX3397
  • Los Angeles, California
  • +5 more
Jun 18, 2020

Solid Tumors Trial in United States (PLX3397, Paclitaxel)

Completed
Has Results
  • Solid Tumors
  • Birmingham, Alabama
  • +7 more
Jul 14, 2020

Tenosynovial Giant Cell Tumor Trial in Worldwide (Pexidartinib)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Scottsdale, Arizona
  • +15 more
Apr 29, 2022

Patients With Newly Diagnosed Glioblastoma Trial in United States (PLX3397, Radiation Therapy, Temozolomide)

Completed
Has Results
  • Patients With Newly Diagnosed Glioblastoma
  • PLX3397
  • +2 more
  • Chicago, Illinois
  • +8 more
Jun 19, 2020

Prostate Cancer Trial in Boston, New York (PLX3397)

Terminated
Has Results
  • Prostate Cancer
  • PLX3397
  • Boston, Massachusetts
  • +1 more
Feb 18, 2020

V600-mutated BRAF Unresectable Melanoma, V600-mutated BRAF Metastatic Melanoma, Stage III or Stage IV Metastatic Melanoma That

Terminated
Has Results
  • V600-mutated BRAF Unresectable Melanoma
  • +2 more
  • Los Angeles, California
  • +5 more
May 12, 2020

Acute Myeloid Leukemia Trial in United States (PLX3397)

Completed
Has Results
  • Acute Myeloid Leukemia
  • PLX3397
  • San Francisco, California
  • +8 more
Feb 18, 2020

Drug Interaction Potential Trial in Worldwide (Tolbutamide, Midazolam, Pexidartinib)

Completed
Has Results
  • Drug Interaction Potential
  • Scottsdale, Arizona
  • +10 more
Apr 19, 2021

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
Has Results
  • Melanoma
  • +4 more
  • PLX3397
  • Pembrolizumab
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Gastric Cancer Trial in Seoul (MCS110/PDR001 combination)

Unknown status
  • Gastric Cancer
  • MCS110/PDR001 combination
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 8, 2019

Rheumatoid Arthritis Trial in United States (PLX3397)

Withdrawn
  • Rheumatoid Arthritis
  • PLX3397
  • Tuscaloosa, Alabama
  • +4 more
Mar 13, 2015